Swapnil Shende

Managed Cardio-Diabetic portfolio across assigned territory.
Achieved 110-125% of annual sales targets consistently.
Delivered 18-22% year-on-year territory growth.
Strengthened KOL engagement and improved prescription share.
Expanded high-potential doctor base and increased market penetration.
Ensured strong stockist coordination and secondary sales growth.

Achieved 105-115% of sales targets.
Improved market penetration and brand recall.
Developed strong doctor and retailer network.